Evidence map›Paper›PMID 30409703›Full record

ArticleMolecular metabolism2019

Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis.

G Wolff, A E Taranko, I Meln, J Weinmann, T Sijmonsma, S Lerch, D Heide, A T Billeter, D Tews, D Krunic and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Fight against fibrosis in adipose tissue remodeling.American journal of physiology. Endocrinology and metabolism · 2021
    Review
  18. A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy.Matrix biology : journal of the International Society for Matrix Biology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

G WolffDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center, Heidelberg, Germany. Electronic address: g.wolff@dkfz-heidelberg.de.
A E TarankoDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center, Heidelberg, Germany.
I MelnDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center, Heidelberg, Germany.
J WeinmannHeidelberg University Hospital, Dept. of Infectious Diseases/Virology, BioQuant Center, Heidelberg, Germany.
T SijmonsmaDivision Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
S LerchDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center, Heidelberg, Germany.
D HeideDivision Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
A T BilleterDepartment of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
D TewsDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany.
D KrunicLight Microscopy Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
P Fischer-PosovszkyDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center, Ulm, Germany.
B P Müller-StichDepartment of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
S HerzigHelmholtz Center Munich, Institute for Diabetes and Cancer IDC, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
D GrimmHeidelberg University Hospital, Dept. of Infectious Diseases/Virology, BioQuant Center, Heidelberg, Germany; German Center for Infection Research, Partner Site Heidelberg, Germany.
M HeikenwälderDivision Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
W W KaoDepartment of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
A VegiopoulosDKFZ Junior Group Metabolism and Stem Cell Plasticity, German Cancer Research Center, Heidelberg, Germany. Electronic address: a.vegiopoulos@dkfz.de.
Heidelberg University · DEGerman Cancer Research Center · DEHelmholtz Zentrum München · DEUniversity Hospital Heidelberg · DEUniversity of Cincinnati · US

Funding

Structure/Function Relationship of The Lumican GeneR01EY011845 · NEI · UNIVERSITY OF CINCINNATI · PI KAO, WINSTON W · 1999 to 2017
$5.2M
NEI NIH HHS R01 EY011845
6 · The paper itself

Abstract

objectiveExtracellular matrix remodeling is required for adipose expansion under increased caloric intake. In turn, inhibited expandability due to aberrant collagen deposition promotes insulin resistance and progression towards the metabolic syndrome. An emerging role for the small leucine-rich proteoglycan Lumican in metabolically driven nonalcoholic fatty liver disease sparks an interest in further understanding its role in diet-induced obesity and metabolic complications.

methodsWhole body ablation of Lumican (Lum

resultsLumican was found to be particularly enriched in the stromal cells isolated from murine gonadal white adipose tissue. Likewise murine and human visceral fat showed a robust increase in Lumican as compared to fat from the subcutaneous depot. Lumican null female mice exhibited moderately increased fat mass, decreased insulin sensitivity and increased liver triglycerides in a diet-dependent manner. These changes coincided with inflammation in adipose tissue and no overt effects in adipose expandability, i.e. adipocyte formation and hypertrophy. Lumican over-expression in visceral fat and liver resulted in improved insulin sensitivity and glucose clearance.

conclusionsThese data indicate that Lumican may represent a functional link between the extracellular matrix, glucose homeostasis, and features of the metabolic syndrome.

Indexed as

AdipocytesAdipose TissueAdipose Tissue, WhiteAdiposityAdultAnimalsDiet, High-FatExtracellular MatrixFemaleGlucoseHomeostasisHumansInsulin ResistanceIntra-Abdominal FatLiverLumicanGlucoseLumicanProteoglycansAdiposeECMInflammationInsulinLumicanObesity

Identifiers

PMID30409703
PMCPMC6323191
OpenAlexW2896492572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.